<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TEST" NEWID="18349" OLDID="7794" TOPICS="NO">
<DATE> 2-JUN-1987 19:04:16.67</DATE>
<TOPICS/>
<PLACES><D>usa</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F
   f2916 reute
u f BC-ALLERGY-GETS-GRANT-TO   06-02 0055</UNKNOWN>
<TEXT> 
<TITLE>ALLERGY GETS GRANT TO DEVELOP INTERLEUKIN KIT</TITLE>
<DATELINE>    NEWPORT BEACH, Calif., June 2 - </DATELINE><BODY>Allergy Immuno Technologies
Inc said it received federal funding to develop a diagnostic
kit for measuring Interleukin-2 and Interleukin-2 receptor.
    Interleukin is a naturally produced substance important in
maintaining the body's immune system.
 Reuter
 </BODY></TEXT>
</REUTERS>